1 / 21

Clinical trials (3)

Manifestation of Novel Social Challenges of the European Union in the Teaching Material of Medical Biotechnology Master’s P rogrammes at the University of Pécs and at the University of Debrecen Identification number : TÁMOP-4.1.2-08/1/A-2009-0011.

falala
Télécharger la présentation

Clinical trials (3)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat theUniversity of Pécs and at the University of Debrecen Identificationnumber: TÁMOP-4.1.2-08/1/A-2009-0011

  2. Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat theUniversity of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Dr. Judit Pongrácz Threedimensionaltissuecultures and tissueengineering – Lecture 25 Clinicaltrials(3)

  3. Tissue engineered blood vessel • TE bloodvesselsareusedonlyinlowpressurepulmonarycirculation • Thesegraftsarenotdurableenoughtowithstandhigharterialpressure Cellisolation Cellexpansion Small-vein harvest Cellseeding onpolymer Tissue-engineeredgraft

  4. TEBV production • A completelybiologicaltissue-engineered human bloodvessel (Nicolas L'heureux, StéphaniePâquet, Raymond Labbé, LucieGermain, and François A. Auger ) FASEB Journal 1998 • HUVEC and SMC wereused

  5. Myocardialinfaction • Stemcellsareusedincasesfollowingextensivedamage • In most casesimprovement is shownbutfurtherstudiesareneeded

  6. Urethra and bladder • Acellularcollagen-basedmatrices • Intestinalorbladderepithelialcells • 4-7 yearslater 34 out of 40 patients had a successfuloutcome

  7. Cartilage • Twomulticentreclinicaltrials • In most casesimprovementwasnoted • Long termeffectsarestill being considered

  8. Lung

  9. Trachea - bronchi - lungs

  10. Lungdiseasesbenefitingfromcellbasedtherapies • COPD (chronicobstuctivepulmonarydisease) • ARDS (acuterespiratorydistresssyndrome) • Asthma • Mechanicaltissuedamages

  11. Strategiesforcell-basedtherapiesforthelung Embryonicstemcells Culture Pulmonaryepithelium Selection (genetic, air liquidinterface, mediaco-culture) Mesenchyme Endothelium Pulmonaryepithelial-likecells Organoid Functional unit ESCs, MSCs, Fibrocytes Intratracheal/Vascularinfusion Structuralgrafts Engraftment Genetransfer Delivery of therapeutic molecules Acutecytoprotection/repair (survival, growthfactors) Engraftment Cartilage Vasculature Epithelium Stroma (fibroblast)

  12. Complexity of lungstructuresduringdevelopment Es Es T T Lungbud Type I cell TypeII cell Columnarcells Gobletcell Ciliated cell Claracell Basal cell Fibroblasts I. Embryonic E 9-12 II. Pseudoglandular E 12-15 III. Canalicular E 15-E17 IV. Saccular E 17-Birth V. Alveolar Birth-PN20

  13. Manifestation of Novel Social Challenges of the European Unionin the Teaching Material ofMedical Biotechnology Master’s Programmesat theUniversity of Pécs and at the University of Debrecen Identification number: TÁMOP-4.1.2-08/1/A-2009-0011 Dr. Judit Pongrácz Threedimensionaltissuecultures and tissueengineering – Lecture 26 Research application and drug testing

  14. Research applications • Intercellularinteraction • Study of Signalingpathway (inter and intra-cellular) • Study of regenerationprocesses • Modelingdiseases

  15. Thymusreaggregation E15 mouseembryo E15 thymiclobes Deoxiguanosinecultures T-lymphocytesor lymphoidprogenitors Thymicepithelialcells Reaggregate

  16. Thymocytedevelopmentinthereaggregatedthymus Stromalcell Jagged/Delta-like Presenilin g-Secretase Lymphocyte progenitor IntracellularNotch (ICN) CoR Nucleus CoA CoR CSL (ICN) CSL • No T-cellcommitment • AllowsB-cellcommitment • InducesT-cellcommitment • BlocksB-cellcommitment

  17. Salivaryglandaggregate GFP-Ad FoxN1-Ad

  18. Tissuespecificchanges • Expression of transcriptionfactors and othergenesareeasilymodified • Geneexpressionmodification is tissuetyperestricted • Effectsonthewholetissuecan be studiedatthelevel of morphology, cellularinteractions and signaling

  19. Drug testing • Toxicity testing • Efficacy testing

  20. Hepatotoxicity testing • Purifiedprimary human hepatocytesin 2D • Complex 3D livermicro-tissuesfortoxicity • Toxicity testing (acute and chronic) • Viabilityassays • Bileproduction • Molecular marker tests (albumin etc)

  21. Lungmodelfordrug testing • Complexcellularcomposition • Closetophysiologicaldrugtransporterexpression • Easyhandling • Suitabilityfor HTS

More Related